Skip to main content

Aspirin / dipyridamole Side Effects

Medically reviewed by Drugs.com. Last updated on Jan 14, 2024.

Applies to aspirin / dipyridamole: oral capsule extended release.

Serious side effects

Along with its needed effects, aspirin/dipyridamole may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking aspirin / dipyridamole:

More common

Less common

Rare

Get emergency help immediately if any of the following symptoms of overdose occur while taking aspirin / dipyridamole:

Symptoms of overdose

Other side effects

Some side effects of aspirin / dipyridamole may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common or rare

For Healthcare Professionals

Applies to aspirin / dipyridamole: oral capsule extended release.

General

The most common adverse reactions were headache, dizziness, dyspepsia, abdominal pain, nausea, and diarrhea.[Ref]

Nervous system

Very common (10% or more): Dizziness (up to 29.5%), headache (28.25%/year)

Common (1% to 10%): Convulsions, syncope, amnesia, somnolence, intracranial hemorrhage

Frequency not reported: Coma, paresthesia, cerebral hemorrhage, subarachnoid hemorrhage, tinnitus, taste loss

Postmarketing reports: Cerebral edema, migraine

Aspirin:

Very common (10% or more): Dizziness (29.2%), headache (22.1%/year)

Common (1% to 10%): Convulsions, syncope, amnesia, somnolence

Frequency not reported: Brain edema, lethargy, tinnitus

Dipyridamole:

Very common (10% or more): Dizziness (30.1%), headache (27.91%/year)

Common (1% to 10%): Convulsions, syncope, amnesia, somnolence[Ref]

Gastrointestinal

Very common (10% or more): Dyspepsia (13.23%/year), abdominal pain (12.62%/year), nausea (11.53%/year)

Common (1% to 10%): Diarrhea, vomiting, rectum hemorrhage, melena, hemorrhoids, gastrointestinal hemorrhage

Frequency not reported: Gastritis, ulceration, perforation, gingival bleeding

Postmarketing reports: Pancreatitis, hematemesis, Reye syndrome, gastritis, ulceration and perforation, melena, GI hemorrhage

Aspirin:

Very common (10% or more): Dyspepsia (11.84%/year), abdominal pain (10.38%/year)

Common (1% to 10%): Nausea, diarrhea, vomiting, rectum hemorrhage, melena, hemorrhoids, gastrointestinal hemorrhage

Frequency not reported: Gingival bleeding, gastric ulcer perforation, duodenal ulcer perforation, melena, hematemesis, pancreatitis

Dipyridamole:

Very common (10% or more): Dyspepsia (12.68%/year), diarrhea (11.31%/year), abdominal pain (11.22%/year), nausea (11.18%/year)

Common (1% to 10%): Vomiting, rectum hemorrhage, melena, hemorrhoids, gastrointestinal hemorrhage[Ref]

Other

Common (1% to 10%): Pain, fatigue, accidental injury, malaise, asthenia

Frequency not reported: Fever, deafness

Postmarketing reports: Hypothermia, chest pain, syncope, hearing loss, prolonged pregnancy and labor, stillbirths, lower birth weight infants, antepartum bleeding, postpartum bleeding

Aspirin:

Common (1% to 10%): Pain, fatigue, accidental injury, malaise, asthenia

Frequency not reported: Deafness, prolonged pregnancy, prolonged labor, stillbirth, lower birth weight infants, antepartum hemorrhage, postpartum hemorrhage, pyrexia, hypothermia

Dipyridamole:

Common (1% to 10%): Pain, fatigue, accidental injury, malaise, asthenia[Ref]

Respiratory

Common (1% to 10%): Coughing, upper respiratory tract infection, epistaxis

Frequency not reported: Hyperpnea, asthma, bronchospasm, hemoptysis, pulmonary edema

Postmarketing reports: Respiratory alkalosis, laryngeal edema, tachypnea, dyspnea

Aspirin:

Common (1% to 10%): Coughing, upper respiratory tract infection, epistaxis

Frequency not reported: Dyspnea, laryngeal edema, hyperventilation, pulmonary edema, tachypnea

Dipyridamole:

Common (1% to 10%): Coughing, upper respiratory tract infection, epistaxis[Ref]

Hematologic

Common (1% to 10%): Hemorrhage not otherwise specified, anemia, major bleeding

Frequency not reported: Hematoma, hemoglobin decreased, hematocrit decreased, erythrocyte count decreased

Postmarketing reports: Prolongation of prothrombin time, disseminated intravascular coagulation, coagulopathy, thrombocytopenia, aplastic anemia, pancytopenia, thrombocytosis, hematoma, gingival bleeding, epistaxis, purpura

Aspirin:

Common (1% to 10%): Hemorrhage not otherwise specified, anemia

Frequency not reported: Disseminated intravascular coagulation, coagulopathy

Dipyridamole:

Common (1% to 10%): Hemorrhage not otherwise specified, anemia[Ref]

Cardiovascular

Common (1% to 10%): Cardiac failure

Frequency not reported: Hypotension, tachycardia, palpitation, arrhythmia, supraventricular tachycardia, flushing

Postmarketing reports: Angina pectoris, hypotension

Aspirin:

Common (1% to 10%): Cardiac failure

Frequency not reported: Arrhythmia

Dipyridamole:

Common (1% to 10%): Cardiac failure[Ref]

Dermatologic

Common (1% to 10%): Purpura

Frequency not reported: Pruritus, urticaria

Postmarketing reports: Rash, alopecia, angioedema, Stevens-Johnson syndrome, skin hemorrhages, bruising, ecchymosis, hematoma, pruritus, urticaria, and drug reaction with eosinophilia and systemic symptoms (DRESS)

Aspirin:

Common (1% to 10%): Purpura

Frequency not reported: Erythema exudativum multiforme

Dipyridamole:

Common (1% to 10%): Purpura[Ref]

Metabolic

Common (1% to 10%): Anorexia

Frequency not reported: Hyperglycemia, thirst

Postmarketing reports: Hyperkalemia, metabolic acidosis, hypokalemia, hypoglycemia, dehydration

Aspirin:

Common (1% to 10%): Anorexia

Frequency not reported: Hyperglycemia, thirst, dehydration, hyperkalemia, metabolic acidosis, respiratory alkalosis

Dipyridamole:

Common (1% to 10%): Anorexia[Ref]

Psychiatric

Common (1% to 10%): Confusion

Frequency not reported: Agitation

Postmarketing: Confusion and agitation

Aspirin:

Common (1% to 10%): Confusion

Frequency not reported: Agitation

Dipyridamole:

Common (1% to 10%): Confusion[Ref]

Musculoskeletal

Common (1% to 10%): Back pain

Postmarketing reports: Rhabdomyolysis, myalgia

Aspirin:

Common (1% to 10%): Back pain

Frequency not reported: Rhabdomyolysis

Dipyridamole:

Common (1% to 10%): Back pain[Ref]

Oncologic

Common (1% to 10%): Neoplasm not otherwise specified

Aspirin:

Common (1% to 10%): Neoplasm not otherwise specified

Dipyridamole:

Common (1% to 10%): Neoplasm not otherwise specified[Ref]

Hepatic

Frequency not reported: Cholelithiasis, jaundice, hepatic function abnormal

Postmarketing reports: Reye's syndrome, hepatitis, hepatic failure, jaundice

Aspirin:

Frequency not reported: Hepatitis, Reye's syndrome[Ref]

Renal

Frequency not reported: Renal insufficiency, renal failure

Postmarketing reports: Interstitial nephritis, papillary necrosis, proteinuria, hematuria

Aspirin:

Frequency not reported: Renal failure, interstitial nephritis, papillary necrosis[Ref]

Genitourinary

Frequency not reported: Uterine hemorrhage, hematuria

Postmarketing reports: Proteinuria

Aspirin:

Frequency not reported: Proteinuria[Ref]

Immunologic

Frequency not reported: Allergic reaction

Postmarketing reports: Hypersensitivity, acute anaphylaxis

Aspirin:

Frequency not reported: Anaphylactic reactions[Ref]

References

1. Product Information. Aggrenox (aspirin-dipyridamole). Boehringer-Ingelheim. 2001;PROD.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

3. Cerner Multum, Inc. Australian Product Information.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.